ATCC 100 Years Logo Anniversary ATCC 100 Years Logo Anniversary Cart 0
SearchLoading
  • Careers
  • Support

Advanced Cancer Models

Fluorescent spheres and particles of green, blue, orange, and yellow.

Advanced biological models are revolutionizing cancer research

We are at an inflection point in cancer research today. New biological models now more closely mimic the behavior of cancer and are standardized, annotated, traceable, and paired with genomic and phenotypic data. These new advanced cancer models are contributing more valuable and reproducible research results than ever before.

ThawReadyâ„¢

Cell-based assays have lengthy timelines due to the requirement of cell expansion processes to get a synchronized cell stock. To speed your timelines while providing you with the consistency you need, ATCC developed ThawReady™. These products are ready within hours of thawing and can streamline your workflow by months—simply thaw, plate, and go!

Epithelial-mesenchymal Transition (EMT)

CRISPR-edited EMT and mesenchymal-epithelial transition (MET) reporter cell lines enable real-time monitoring of the transition of cells from epithelial to mesenchymal state (or the reverse) via the expression of red fluorescent protein (RFP)–tagged vimentin or green fluorescent protein (GFP)–tagged E-cadherin.

Human Cancer Models Initiative (HCMI)

As part of our pledge to elevate biological models, ATCC is collaborating with HCMI to offer scientists a wide variety of next-generation 2-D and 3-D patient-derived in vitro cancer models, including organoids, neuronal models, and conditionally reprogrammed cells. 

Immuno-oncology models

The development of immunomodulatory drugs and biologics dictates a clear need for human cell-based models to evaluate immune activation. To answer this need, ATCC provides a large collection of fully characterized and authenticated advanced cell models, including checkpoint luciferase reporter cells, CAR-T luciferase reporter cells, and THP-1 reporter cells.

Isogenic Cell Models

Clinically relevant cell models are critical for studies of molecular and cellular mechanisms of tumors, as well as for drug screening for cancer. Using CRISPR/Cas9, ATCC has created isogenic cell lines with mutants of key oncogenes, which are ideal for identifying novel, personalized treatment regimens.

Luciferase

ATCC is bridging the gap between the in vitro and the in vivo by offering luciferase-labeled cell lines for biological mechanism studies and drug development; these advanced models provide a relatively simple, robust, and highly sensitive means to measure biological processes and to assess drug efficacy in live animal models through bioluminescence imaging.

Organoids

Organoids are self-organizing microtissues that serve as invaluable preclinical models for studying cancer and offer many advantages over existing human or non-human animal cancer models.

Explore the advanced cancer models in our collection.

CRC-day5-488-dapi-day5-2.jpg

Human Cancer Models Initiative (HCMI)

ATCC is collaborating with the Human Cancer Models Initiative (HCMI) to offer scientists a wide variety of next-generation 2-D and 3-D patient-derived in vitro cancer models, including organoids. These HCMI models are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research. 

Explore the collection
A bright-green, fluorescent, EGFR stain sphere with a black background.

Isogenic Cells

Clinically relevant cell models are critical for studies of molecular and cellular mechanisms of tumors, as well as for drug screening for cancer. Using genome editing tools such as CRISPR/Cas9, ATCC has created isogenic cell lines with mutants of key oncogenes, which are ideal for identifying novel treatment regimens.

Get More Info

Watch our webinar about the HCMI

Advanced Cancer Models

SearchLoading

Refine by

Product category
Clear
    Product type
    Clear
      Product application
      Clear
        Product format
        Clear
          Biosafety level
          Clear
            Verification method
            Clear
              Organism
              Clear
                Tissue
                Clear
                  Cell type
                  Clear
                    Disease
                    Clear
                      Disease stage
                      Clear
                        Disease type
                        Clear
                          Metastatic
                          Clear
                            Tumorigenic
                            Clear
                              Growth properties
                              Clear
                                Ethnicity
                                Clear
                                  Gender
                                  Clear
                                    Nucleic acid type
                                    Clear
                                      DNA or RNA
                                      Clear
                                        Available for licensing
                                        Clear
                                          Resource Type
                                          Clear
                                            Results per page